WATERTOWN, Mass.--(BUSINESS WIRE)--C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been appointed as President and Chief Executive Officer. Dr. Phillips has been leading C4T’s ...
CAMBRIDGE, Mass. – February 2, 2016 – C4 Therapeutics today announced the appointment of Andrew Phillips, Ph.D. as Chief Scientific Officer. Dr. Phillips joins from the Broad Institute of MIT and ...